Abiopharma

🔍 Richmond Raphaell Z. (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 6,797 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,056.00 | transaction_form_type: 4
• Sold 354 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 46,702.00 | transaction_form_type: 4
• Sold 551 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 46,151.00 | transaction_form_type: 4
• Acquired 1,732 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,883.00 | transaction_form_type: 4
• Sold 496 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 47,387.00 | transaction_form_type: 4
• Acquired 4,804 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,191.00 | transaction_form_type: 4
• Sold 1,374 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 50,817.00 | transaction_form_type: 4
• Acquired 1,422 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,239.00 | transaction_form_type: 4
• Acquired 1,344 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 53,583.00 | transaction_form_type: 4